Nocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD

Qin Wang1, Yu Wang1, Jinwei Wang1

  • 1Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, National Health and Family Planning Commission of the People's Republic of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing, China.

Insights

Nocturnal systolic hypertension, alone or combined, elevates risks for cardiovascular events and kidney failure in chronic kidney disease (CKD) patients. Isolated nocturnal diastolic hypertension showed no significant association with adverse outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Nocturnal hypertension is linked to poor outcomes in chronic kidney disease (CKD).
  • The specific impact of different nocturnal hypertension types on CKD progression and cardiovascular events remains unclear.

Purpose of the Study:

  • To investigate the association between distinct entities of nocturnal hypertension and the risks of kidney failure and cardiovascular events in CKD patients.
  • To clarify the prognostic value of isolated nocturnal systolic hypertension, isolated nocturnal diastolic hypertension, and combined nocturnal systolic-diastolic hypertension.

Main Methods:

  • Analysis of data from the Chinese Cohort Study of Chronic Kidney Disease.
  • Categorization of nocturnal hypertension into isolated diastolic, isolated systolic, and systolic-diastolic types.
  • Utilized Cox regression to assess associations with kidney failure and cardiovascular outcomes.

Main Results:

  • Among 2024 CKD patients, 73% had nocturnal hypertension.
  • Isolated nocturnal systolic hypertension (8% of cases) increased cardiovascular event risk (HR, 3.17).
  • Nocturnal systolic-diastolic hypertension (66% of cases) elevated risks for both kidney failure (HR, 1.71) and cardiovascular events (HR, 2.19).
  • Isolated nocturnal diastolic hypertension showed no significant association with adverse outcomes.

Conclusions:

  • Nocturnal systolic hypertension, whether isolated or combined, is a significant risk factor for adverse outcomes in CKD.
  • These findings highlight the importance of monitoring systolic blood pressure during nighttime in CKD management.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
352
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
142
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
202
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
326
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191